| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |